Page last updated: 2024-08-25

nobiletin and Parkinsonian Disorders

nobiletin has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukunaga, K; Mimaki, Y; Ohizumi, Y; Yabuki, Y; Yokosuka, A	1

Other Studies

1 other study(ies) available for nobiletin and Parkinsonian Disorders

Article	Year
Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice. Neuroscience, 2014, Feb-14, Volume: 259 Topics: Animals; Antioxidants; Avoidance Learning; Brain; Calcium Channel Blockers; Cognition Disorders; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Flavones; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Parkinsonian Disorders; Psychomotor Performance; Signal Transduction	2014

Article

Year

Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.

Neuroscience, 2014, Feb-14, Volume: 259

Topics: Animals; Antioxidants; Avoidance Learning; Brain; Calcium Channel Blockers; Cognition Disorders; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Flavones; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Parkinsonian Disorders; Psychomotor Performance; Signal Transduction

2014